Shao X, Tandon R, Samara G, Kanki H, Yano H, Close L G, Parsons R, Sato T
Department of Otolaryngology/Head and Neck Surgery, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.
Int J Cancer. 1998 Aug 31;77(5):684-8. doi: 10.1002/(sici)1097-0215(19980831)77:5<684::aid-ijc4>3.0.co;2-r.
Loss of heterozygosity (LOH) at chromosome band 10q23 occurs frequently in a wide variety of human tumors. A recently identified candidate tumor suppressor gene, PTEN located on 10q23, is mutated in multiple advanced cancers. To explore whether PTEN is associated with human squamous cell carcinoma of the head and neck (SCCHN), DNAs from both normal muscle and tumor tissue in 19 SCCHN were used for detecting LOH at chromosome 10q23 and mutational analysis of PTEN by direct polymerase chain reaction (PCR)-DNA sequencing. LOH at 10q23 was identified in 6/15 SCCHN. Mutation of PTEN was identified in 3/19 SCCHN. Of these 3 patients, 2 had stage IV disease; the third patient, with recurrent, metastatic and stage III disease, showed a 36 bp germline heterozygous deletion within intron 7. Furthermore, a missense mutation at codon 501 (TCT --> TTT: Ser --> Phe) in exon 8 was also found in tumor from the same patient. Our results suggest that PTEN may play a role in the genesis of some SCCHNs.
10q23染色体带杂合性缺失(LOH)在多种人类肿瘤中频繁发生。最近鉴定出的一个候选肿瘤抑制基因PTEN定位于10q23,在多种晚期癌症中发生突变。为了探究PTEN是否与人类头颈部鳞状细胞癌(SCCHN)相关,对19例SCCHN患者的正常肌肉组织和肿瘤组织的DNA进行检测,以分析10q23染色体的LOH情况,并通过直接聚合酶链反应(PCR)-DNA测序对PTEN进行突变分析。在15例SCCHN中有6例检测到10q23的LOH。在19例SCCHN中有3例检测到PTEN突变。在这3例患者中,2例为IV期疾病;第3例患者患有复发性、转移性III期疾病,其第7内含子存在一个36 bp的种系杂合性缺失。此外,在同一患者的肿瘤中还发现外显子8第501密码子处的错义突变(TCT --> TTT:Ser --> Phe)。我们的结果表明,PTEN可能在某些SCCHN的发生中起作用。